Live Cannabis Europa 2026 London, UK From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes Arjan Roskam, Green House Genetics; Dave Auger, Big League Genetics; Adele Hollman, Sanity Group; moderated by Alex Fraser, Grow Group Telemedicine in Germany: Maturity, Regulation and What Comes Next Kristine Lütke, 365 Sherpas GmbH; Dirk Heitepriem, German Cannabis…
CANTOURAGE has become the third and largest major European medical cannabis operator to go public this year, as investment confidence in the cannabis sector shows further signs of recovery.
A NUMBER of key changes appear to have been made to Germany’s draft adult-use cannabis legalisation proposals after the Health Minister’s ‘key points’ paper was leaked to the press last week.
LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total funding to date to over €100m.
NORTH American investment in the European cannabis industry has grown at pace over the last few years, with hundreds of millions in capital flooding into the region from across the Atlantic.
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US.
WITH negotiations underway on the formation of a new German government supporters of a regulated adult-use cannabis market believe a significant moment in European history beckons.
Berlin headquartered Sanity Group is not only beloved of celebrities but recently completed the biggest ever European Series A funding round for cannabis-based products raising an impressive €35m.
BERLIN-headquartered Sanity Group has confirmed it has completed a $44.2m Series A financing round led by Swiss venture capital firm Redalpine – bringing total investment in the cannabis start-up to $73m.
